Skip to main content
. 2022 Oct 13;13:985911. doi: 10.3389/fimmu.2022.985911

Figure 10.

Figure 10

Internal validation of the robust ECM-APP in the test2 cohort. (A) Sectionalization premised on the median risk score. (B) Survival status and risk score distributions. (C) Heatmap illustrated the expression profiles of 9 genes integrated into the prognostic signature. (D) Survival curve of OS time in low-risk and high-risk subgroups. (E) ROC curve of 1-, 2-, and 3-years of in test2 cohort, area under the curve (AUC) of the curve are 0.771, 0.775, and 0.818, correspondingly. (F) Univariate cox regression analysis showed the independence of risk score, stage, grade, gender, and age. (G) Multivariate cox regression analysis showed the independence of risk score, stage, grade, gender, and age.